barium has been researched along with 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Briggs, CA; McKenna, DG; Piattoni-Kaplan, M | 1 |
1 other study(ies) available for barium and 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
| Article | Year |
|---|---|
Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands.
Topics: Anti-Anxiety Agents; Barium; Benzylidene Compounds; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Chloride Channels; Dose-Response Relationship, Drug; Humans; Isoxazoles; Ligands; Membrane Potentials; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Pyridines; Pyrrolidines; Receptors, Nicotinic; RNA, Messenger | 1995 |